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Abstract The presence of isoenzymes mediating the conversion of thyroxine to 3,5,3’-triiodothyronine has been studied according to characteristic 
kinetics and physiological regulation. In this paper, we report the expression of type II 5’-deiodinase (5’D) activity in oocytes of Xenopus laevis. 
Oocytes injected with total RNA extracted from rat Harderian gland, and then incubated up to five days demonstrated a progressive increase in 5’D 
activity, reaching a maximal value at 24 h; then, SD activity remained almost stable for an additional period of four days. Characteristics of the 
enzyme activity expressed by oocytes included its inhibition by iopanoic acid, but not by propylthiouracil, and its increase during/?-adrenergic agonist 
treatment and hypothyroidism. The expressed activity manifests characteristics typical of the type II isoenzyme. Deiodinating activity in oocytes also 
exhibited diurnal variations. In this study, 5’D activity expressed in oocytes exhibited low values when animals were killed during the day, and high 
values when animals were killed at night. Maximal values were reached 34 h before the nocturnal peak of 5’D activity in Harderian gland crude 
homogenates. Results uggest that the in vivo activation of 5’D by isoproterenol, hypothyroidism, or dark exposure may be caused by an increase 
in the synthesis and/or maturation of the RNA expressing the enzyme. 
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1. Introduction 
In man and experimental animals most triiodothyronine (T,) 
is produced by extrathyroidal 5’-monodeiodination of thyrox- 
ine (TJ [l]. This process is catalyzed by enzymes found in 
microsomes of several tissues. At least two types of thyroxine 
S-deiodinase (5’D) have been studied and classified according 
to kinetic characteristics and physiological regulation. This in- 
cludes a high K,,, SD in the range of l-5 micromolar which is 
mainly present in liver [2] and kidney [3] (type I isoenzyme), and 
plays an important role in maintaining serum T, levels. Another 
isoenzyme is present in specific tissues including anterior pitui- 
tary [4], brain [5], brown adipose tissue [6], and epidermal ker- 
atinocytes [7]. This isoenzyme exhibits a lower K,,, in the range 
of l-5 nM (type II isoenzyme) when dithiothreitol is used as 
cofactor, is sensitive to inhibition by iopanoic acid (IOP), and 
increases its activity during hypothyroidism [8]. Thus, it is be- 
lieved to have an important role in maintaining intracellular 
levels of T, and could serve as a defense against thyroid 
hormone deficiency. During the last few years, the presence of 
type II SD activity was also identified in pineal [9-l l] and 
Harderian glands [12,13]. In both glands, the activity of the 
deiodinating enzyme increases with hypothyroidism and exhib- 
its a marked nyctohemeral profile reaching maximal values late 
in the dark period, Since no specific reagents for quantitation 
of the enzyme have been developed, it has not been possible to 
confirm that these activity changes are due to alterations in the 
enzyme content or, if so, whether they are transcriptional or 
post-transcriptional. 
Several attempts have been made to isolate the type I SD 
isoenzyme, but have been unsuccessfuyl, apparently because 
there is substantial inactivation of 5’D activity during the iso- 
lation procedures used [14,15]. A growing number of pro- 
teins, including intracellular enzymes and cell surface receptors, 
have been found to amenable to study after expression in 
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Xenopus Zuevis oocytes. Using this system, the expression of 
type I S-deiodinase has been reported [16], providing new in- 
formation concerning the biochemical characteristics of this 
isoenzyme. However, little is known about the properties of the 
type II isoenzyme. 
The aim of this work is to characterize the expression of the 
type II 5’D isoenzyme using Xenopus laevis oocytes as an in 
vivo translational assay system to identify total RNA. Results 
show that the type II isoenzyme can be induced in Xenopus 
laevis oocytes by the injection of total RNA from rat Harderian 
gland. 
2. Materials and methods 
2.1. Animals 
Wistar rats of both sexes born in our animal facilities were used. 
Animals received food and water ad libitum and were exposed to an 
automatically regulated light/dark cycle of 14: 10 h; the lights were 
turned off daily from 20.00 through 06.00 h. When required, animals 
were rendered hypothyroid by adding 20 mg/lOO ml methimazole to the 
drinking water; this treatment was maintained for 10 days before the 
animals were used for the experiments. On the day of the experiment, 
animals were killed by decapitation at the times indicated, and 
Harderian glands were quickly collected, frozen on solid CO*, and 
stored at -80°C until used. 
2.2. Preparation of total RNA 
Total RNA was isolated from rat Harderian gland using the method 
of Chomczynski and Sacchi [17]. Harderian glands (1 g) were homoge- 
nized with 10 ml of 4 M guanidinium thiocyanate, 25 mM sodium 
citrate, pH 7, 0.5% sarcosyl, 0.1 M 2-mercaptoethanol, and after both 
the extraction and precipitation with isopropanol, the resulting RNA 
pellet was dissolved in water for injection into oocytes. The yield of total 
RNA was measured by the optical density at 260 nm. 
2.3. Microinjection of total RNA into Xenopus laevis oocytes 
Xenopus laevis oocytes were microinjected with RNA according to 
the general method of Coleman [18]. Female Xenopus laevis frogs (Cen- 
tre d’Elevage de Xenopes du CRBM, Montpellier, France) were anes- 
thetized by hypothermia and ovarian lobes removed through an 
abdominal incision and placed into 5 mM HEPES buffer, pH 7.5, 
containing 82.5 mM NaCl, 2 mM KCl, 1 mM MgCl, (OR2 solution). 
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Oocytes were dissected from the ovarian tissue and incubated for 45 
minin collagenase (type II, Sigma); then, washed extensively in OR2 
solution and incubated overnieht in 5 mM HEPES medium. DH 7.5. 
containing 96 mM NaCl, 2 GM KCI, 1.8 mM KC],, 1 rnc MgCl; 
(ND96 medium). Oocytes were injected with 50 nl(1 ng/nl) of a solution 
of total RNA in sterile water. Typically, 12 oocytes were injected with 
each RNA preparation; then, they were incubated in ND96 medium 
containing 25 mg/ml streptomycin with daily medium changes. After 
incubation, oocytes were frozen at -8O’C until the quantitation of 5’D 
activity. 
2.4. Type II thyroxine S-deiodinase assay 
The measurement of type II 5’D activity was based on the release of 
radioiodine from [3’,5’-“‘I]T,. This method, commonly used in 
Harderian gland studies [ 12,131, is sensitive nough for Harderian 5’ D 
determinations and is specific for SD deiodinase since the substrate 
contains “‘1 only in position 5’. Other deiodinating activities, i.e. con- 
version of T4 to rT,, would release only nonradioactive iodide. Type II 
SD activity was determined in groups of 12 oocytes. Each group was 
disrupted bv ultrasound in cold 0.05 M nhosnhate buffer, DH 6.8; then, 
50 pl’were incubated in the presence oi40 AM DTT and 2 nM’[3’,5’: 
?]T4 as substrate (200 ~1 final volume). The reaction was started by 
the addition of the substrate and continued for 60 min at 37°C. Control 
incubations were performed by omission of the homogenate. The reac- 
tion was terminated by the addition of 100 ~1 cold BSA (2%) and 750 
~1 trichloroacetic acid (10%). Samples were centrifuged for 30 s at 
10,000 rpm and 500 ~1 of the supernatant were placed onto a 0.5 ml 
column packed with Dowex-SOW ion-exchange resin and washed with 
500 ~1 of 10% glacial acetic acid. Radioactivity in the eluate, corre- 
sponding to the ‘? released, was counted in a gamma counter as an 
index of SD activity. The recovery of ‘251 in this process was better than 
95%. Specific activity was determined by subtracting the control value, 
which usually amounted to less than 1% of the radioactivity added. 5’D 
activity is referred to as fentomoles ‘**I released/100 oocyteslh or fento- 
moles “‘1 released/mg protein/h. When required, proteins were deter- 
mined by the method described by Lowry et al. [19]. Results are 
expressed as means f standard errors (S.E.). Data were statistically 
analyzed using an ANOVA followed by a Student-Newman-Keuls 
multiple range test. 
2.5. Reagents 
All reagents were of analytical grade and obtained from commercial 
sources. T,, o,L-dithiothreitol (DTT), methimazole, 6-n-propyl-2- 
thiouracil (PTU), (-) isoproterenol, and Dowex-SOW were purchased 
from Sigma (St. Louis, MO); iopanoic acid (IOP; Telepaque, 3-[3- 
amino-2,4,6-triiodophenyll-2-ethylpropionic acid) was generously sup- 
plied by Dr. Thielking, Sterling-Winthrop Research Institute (Rensse- 
laer, NY). Na? was purchased from Amersham (Amersham, Bucks, 
UK). ‘25I was bound to T, using the chloramine-T method, as described 
by Nakamura et al. [20]. [3’,5’-1251]Tq waspurified on a 3-ml Sephadex 
LH-20 column, containing the purified tracer and less than 2% free 
iodine, and immediately used for 5’ D analyses. 
3. Results and discussion 
Results demonstrate, for the first time, that type II thyroxine 
SD can be induced in Xenopus laevis oocytes by the injection 
of total RNA isolated from rat Harderian gland. The expressed 
activity manifests characteristics typical of the type II enzyme. 
The time course of expression of SD activity in oocytes after 
injection of RNA total shows that the activity can be detected 
at 12 h, but the maximal value is reached at 24 h and, after this 
time, the expression is maintained almost stable (Fig. 1, top). 
Therefore, further incubations were performed for 24 h to pro- 
vide maximal deiodinating activity. Other authors investigated 
the expression in Xenopus laevis of type I thyroxine SD, and 
have demosntrated aprogressive increase in this activity for up 
to 5 days [16]. The differential timing of the induction of both 
isoenzymes upports the critical importance of extrathyroidal 
5’ monodeiodination of T4 in different tissues. 
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Fig. 1. (Top) Time course of expression of 5’D activity in Xenopus laevis 
oocytes. Oocytes were injected with 50 ng of total RNA extracted from 
Harderian gland of hypothyroid rats. Groups of 12 oocytes were incu- 
bated for the times indicated. Results are the mean of 2 experiments 
performed in triplicate. (Bottom) Oocytes were injected with 50 ng of 
total RNA extracted from Harderian gland of hypothyroid rats. After 
24 h incubation, oocytes were sonicaied and 5’fi activity was deter- 
mined in the absence (C) or presence of 1 mM IOP or 1 mM PTU. 
Results are the mean i S.E. df 3 experiments performed in triplicate. 
A characteristic of the type II SD isoenzyme is the different 
sensitivity of the enzyme to inhibition by PTU and IOP acid. 
As shown in Fig. 1 (bottom), the enzyme activity was insensitive 
to PTU, but was inhibited by IOP acid (70%). Because these 
characteristics define the type II thyroxine deiodinating path- 
way in other tissues [21], we suggest hat SD expressed by 
oocytes also shares this pathway. 
The mechanisms involved in regulating Harderian gland 5’D 
have been studied in vivo [ 12,131. In Harderian gland, besides 
the thyroid status, 5’D activity is regulated by the light-dark 
cycle, exhibiting a progressive rise in activity after the onset of 
the dark period and reaching a peak value 5-6 hours later 
[12,22]. This nocturnal increase in 5’D activity seems to be 
dependent on the sympathetic noradrenergic input [22]. In ad- 
dition, in vivo studies have shown that isoproterenol, a 
p-adrenergic agonist, activates 5’D activity, while propranolol, 
a /3-adrenergic blocker, inhibits it [23,24]. The mechanisms in- 
volved in this regulation are not well understood. In this paper 
we support the hypothesis that synthesis and/or maturation of 
RNA can be involved in the regulation of SD activity. Thus, 
we studied the induction of type II 5’D activity in Xenopus 
laevis oocytes from rats maintained under different treatments. 
Both euthyroid and hypothyroid animals were injected with 
isoproterenol, and the isolated total RNA from Harderian 
gland, confirmed that isoproterenol treatment and/or hypothy- 
roid status induced an increase in the expression of the enzyme 
(Fig. 2). 
Additional experiments were performed to investigate the 
diurnal variations in the expression of 5’D activity in Xenopus 
laevis oocytes. Harderian glands of hypothyroid rats were col- 
112 J. E Garcia-Mach et al. I FEBS Letters 354 (1994) 110-I 12 
75 
t 
a, p<O.Ol vs SAL 
a 
73 I 
SAL IS0 MET MET 
S+AL 20 
Fig. 2. Expression of 5’D activity in Xenopus laevis oocytes injected 
with total RNA under different conditions. Oocytes were injected with 
50 ng of total RNA extracted from Harderian gland of rats maintained 
under the following conditions. Two groups ofeuthyroid animals were 
iniected with either saline (SAL) or isouroterenol(1 ma/kg BWI (ISO). 
Two additional groups were ’ rendered hypothyroid administering 
methimazole in the drinking water for 10 days, and also injected with 
saline (MET + SAL) or isoproterenol (MET + ISO); animals were 
injected with drugs at 12.00 and 14.00 h; then animals were killed at 
16.00 h and Harderian glands were quickly removed and stored at 
-80°C until used to extract otal RNA. Results are the mean f S.E. of 
3 experiments performed in triplicate. 
lected at the times indicated, and the extracted total RNA was 
injected in oocytes to measxure SD activity expression. 5’D 
activity was determined in parallel in the Harderian gland crude 
homogenates. As shown in Fig. 3, the enzyme activity in crude 
homogenates exhibited low values during the daytime; then, 
activity increased after entering the dark period, and reached 
the maximal values at 04.00 h. Type II 5D activity expressed 
by total RNA injected in oocytes exhibited a similar pattern, 
with low values during the day and high values at night. How- 
ever, the nocturnal peak value was reached between 00.00 and 
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Fig. 3. Diurnal variations in the expression of S’D activity in Xenopus 
laevis oocytes. Harderian glands of hypothyroid rats were collected at 
the indicated times; then, the extracted total RNA was injected in 
oocytes and 5’D activity was determined (0). Simultaneously, SD 
activity was also determined in Harderian gland crude homogenates 
(0). Data are the mean of 2 experiments performed in triplicate. 
00.02 h, 34 h before the nocturnal peak of 5’D activity in 
Harderian gland crude homogenates. 
In conclusion, we have shown that type II thyroxine 5’D can 
be induced in Xenopus Iaevis oocytes by the injection of total 
RNA from rat Harderian gland. The expressed activity mani- 
fests characteristics typical of the type II isoenzyme. Results 
also suggest hat, in addition to other possible mechanisms, the 
in vivo activation of 5’D by isoproterenol, hypothyroidism, or 
dark exposure may be caused by an increase in the synthesis 
and/or maturation of the RNA expressing the enzyme. 
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